Procter & Gamble Health per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY27Jun 2026FY26Jun 2025FY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
₹214.99₹57.92₹39.87₹121.07₹138.23
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
₹214.99₹57.92₹39.87₹121.07₹138.23
———₹324.24₹452.34
₹863.22₹219.10₹204.06₹693.53₹740.73
———₹137.52₹142.16
———₹124.43₹116.57
———₹249.99₹56.50
1.71.71.71.71.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,399.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,962 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Current/LTM
TTM · last close
Basic EPS138.23121.0739.8757.92214.99
Diluted EPS138.23121.0739.8757.92214.99
Book Value per Share452.34324.24———
Revenue per Share740.73693.53204.06219.10863.22
Cash Flow per Share142.16137.52———
Free Cash Flow per Share116.57124.43———
Dividends per Share56.50249.99———
Shares Outstanding (cr)1.71.71.71.71.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.